Vision therapy helps brain injury patients

Article

Stroke and traumatic brain injury survivors, who have undergone vision restoration therapy (VRT), demonstrate increased brain activity, according to researchers from Columbia University Medical Center, USA.

Stroke and traumatic brain injury survivors, who have undergone vision restoration therapy (VRT), demonstrate increased brain activity, according to researchers from Columbia University Medical Center, USA.

Randolph Marshall and colleagues examined the functional magnetic resonance imaging (fMRIs) of six patients aged between 35 and 77 with homonymous hemianopia vision loss caused by stroke or traumatic brain injury. Each patient underwent VRT therapy to help rehabilitate their vision.

The fMRI data showed that there was an increased activity in the visual processing areas of the brain as patients learned to detect stimuli in the border zone between the seeing and non-seeing fields. This enhanced activity was identified one month after the start of treatment, suggesting that the brain responds accordingly.

The treatment involves patients performing daily therapy at home for between six and seven months, gradually improving their vision through repeated detection of light stimuli directed at the border between the seeing and blind areas of the visual field.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.